J&J plans to deliver 20 million doses of its COVID-19 vaccine in the U.S. in March

Shares of Johnson & Johnson were down 0.1% in premarket trading on Tuesday after the company said in testimony released in advance of a congressional hearing that it plans to deliver about 20 million doses of its COVID-19 vaccine by the end of March.